Canagliflozin and cardiovascular and renal events in type 2 diabetes
Medical Clearance Checklist Before Restarting Semaglutide Before resuming semaglutide, confirm with your surgeon that you meet these key readiness markers: you're eating solid foods without pain or significant nausea, you've stopped prescription opioid pain medications (or your surgeon cleared their use alongside GLP-1 therapy), and at least 48 hours have passed since your last dose of general anesthesia or sedation
These medications target receptors in the brain specifically in the hypothalamus and hindbrain to curb appetite and reduce constant thoughts about food, often referred to as "food noise." "Lots of people describe it as decreasing food noise, which means how much you think about food and how much you crave different foods." Evan Nadler, MD, MBA, Adjunct Associate Professor, George Washington University Myth 5: GLP-1 Medications Are Only for Type 2 Diabetes Although GLP-1 medications were initially created to manage diabetes, they now have FDA approval for chronic weight management in people without diabetes
Seed DS-01 Daily Synbiotic The capsule-in-capsule technology is especially impressive it helps protect the beneficial bacteria as they travel through the stomach so more of them reach the intestines where theyre intended to work
Meaning lower doses keep their efficacy and avoiding the physiological side effects associated with increasing doses
